NHS TAYSIDE. Special Formulation and Unlicensed Products in Primary Care. A Guide for Pharmacists Working Within NHS Tayside

Similar documents
NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Barnett Wood Pre-School. Medication Policy and Procedure

CMS Change Request User Guide. Required April 1, Consolo Services CMS Change Request 8358 User Guide P a g e 1

Obtaining Controlled Drugs In Primary Care - Supply Routes In Exceptional Circumstances

Growing Enterprise ERDF GRANT FUNDING PROCEDURES

Key Points for Approving Officers Regarding Electronic Filing

SAMPLE- Visit FirehouseSubsFoundation.org to apply online. Firehouse Subs Public Safety Foundation Grant Application

Patient Instructions for Home Medical Equipment

Archive and Destruction of Patient Records

Medicaid EHR Incentive Program Eligible Professionals

WHAT IS CAL MEDICONNECT? Cal MediConnect is a health plan that combines all of the benefits you now get from Medicare and Medi-Cal into a single plan.

Original Date: January 27, 2010 Reviewed/Last Modified Date: September 15, 2015

BROCKTON AREA MULTI-SERVICES, INC. ORGANIZATION AND POLICY GUIDE

For purposes of this Security Agreement, the use of the terms you and your includes both the Oil and Gas Operator and the EFA when appropriate.

Oregon Registry. Infant Toddler Professional Credential. Overview. Oregon Center for Career Development in Childhood Care and Education

Medical Conditions Policy

BEHAVIORAL HEALTH STAFF COVERAGE PROTOCOL. Psychiatrist and Psychologist Coverage Plan...4. Telemedicine.7

Access to Mental Health Care Assessment and Treatment - General. Document author Assured by Review cycle. Quality and Safety Committee

Patient Instructions for Home Medical Equipment

Choose Pharmacy Application Frequently Asked Questions (FAQs)

Quincy University Grants Development & Management Guide

DOCUMENT TITLE: Clarification of Bureau of Primary Health Care Credentialing and Privileging Policy outlined in Policy Information Notice

POLICY ON NURSE PRESCRIBING OF MEDICAL IONISING RADIATION 1

LSU HEALTH SHREVEPORT NOTICE OF PRIVACY PRACTICES FOR PROTECTED HEALTH INFORMATION

WORCESTERSHIRE AREA PRESCRIBING COMMITTEE Guidelines for Prescribing Stoma Appliances and Accessories in General Practice

2018 HBS New Venture Competition Student Social Enterprise Track

SICK LEAVE - PANEL MEMBERS

CITY OF MELBOURNE APPLICATION FOR DOWNTOWN MELBOURNE CRA RETAIL CORE COMMERCIAL LIGHTING PROGRAM

Guide to Complete the Steps for Foreign-Trained Nurses to Obtain the Maryland Registered Nurse (RN) License

JOB DESCRIPTION. Director of Corporate Affairs and Governance. Corporate Affairs and Governance (1.0 WTE)

Integrated Sexual Health Services MMPR012 CONTRACEPTIVE INJECTION PROTOCOL. Page 1 of 8

Smart Energy GB in Communities Fund Small grants. Grant Guidelines May 2016

Instructions. Important Dates. Application Deadline: May 15, 2013 at 5:00 p.m. Grant Awards Announced: July 15, 2013

Terminating the Provider- Patient Relationship. Provided by Coverys Risk Management

Working Location: Science Council office in Farringdon, London. With some London and UKtravel

APA Title Program. Information Booklet

RAF CENTRAL FUND 2018 INDIVIDUAL AND GROUP SPORTS GRANTS FUNDING POLICY

Government of Ontario IT Standard (GO-ITS) GO-ITS Number 56.5 OPS Grants Management Reference Model

IHSS In Home Support Services

Safety in Practice Compliance and Risk Assessment Procedure January, 2017

Work Instruction Patient Visits

Administration of First Aid Policy

Frequently asked questions about health identifiers August 2015

EXPLANATORY NOTES. (applicable from 1 July 2015) STAGE 1 DESKTOP ASSESSMENT. for the RECOGNITION OF OVERSEAS OCCUPATIONAL THERAPY QUALIFICATIONS

Use of Fixed Term Contracts within. This document is intended to support managers and staff understand the use of fixed term contracts

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

Policy on Supporting pupils with Medical Conditions

Practice Improvement Network (PIN) Project Application

Who is authorized to give consent (substitute decision makers) Health Care Consent Act

About this guide 5 Section 1: Meeting VET sector requirements 7

SUBJECT/TITLE: Medication Preparation and Administration for Undergraduate Nursing Students (Calgary Campus and Medicine Hat College Site)

Valdez Beautification 2017 Matching Grant Program

OVERTON PARK SURGERY JOB DESCRIPTION

Secomb Conference and Travel Fund

AGENCY NAME - Crisis Stabilization Services

Resident Assistant Application

Learning Together From Safeguarding Adult Reviews

CITY OF MELBOURNE APPLICATION FOR OLDE EAU GALLIE RIVERFRONT CRA FAÇADE IMPROVEMENT PROGRAM

Inpatient Rehab/LTLD Discharge Planning Practices Pre- and Post-Implementation Survey Results of TC LHIN Hospitals

CANADA-JERUSALEM CO-DEVELOPMENT AND CO-PRODUCTION INCENTIVE GUIDELINES 2017

Denver Public Schools. Financial Services. Financial Services Manual. Grants

Medical Assistance in Dying: Update Stakeholder Presentation

The Fact-Finding portion of the Deep End System Assessment is a two-part process that helps lay the foundation for a deeper analysis:

CANADIAN FOUNDATION FOR DIETETIC RESEARCH LA FONDATION CANADIENNE DE LA RECHERCHE EN DIETETIQUE

Cambridgeshire Escalation Policy - Resolution of Professional Disagreements in Safeguarding Work

Health Care Practitioner Authorization Required Yes. Must be in original container with original label containing the name of the child affixed.

CLINICAL PLACEMENT SHIFT and ROSTERING GUIDELINES: Nursing and Midwifery 2018 Sem 1

VOLUNTEER SERVICES APPLICATION PACKAGE

CLINICAL PLACEMENT SHIFT and ROSTERING GUIDELINES: Nursing and Midwifery

Residential Mental Health Treatment for Children and Adolescents

Changes in the Scope of Practice Environment for Nurse Practitioners in Michigan

The information and instructions below are for College of Business Administration [Departmental] Scholarships only.

SUMMER 2018 BACCALAUREATE TO ASSOCIATE DEGREE NURSE ACCELERATED PATHWAY APPLICATION

SCHEDULE 2 THE SERVICES

Tourism Events Grants. FY 2019 (July 1, 2018 June 30, 2019)

Directions & Instructions for Filing an Application to the Radiologic Technology Program

Bulletin. Required Activity: Admission to Medicaid-Certified Nursing Facilities and 90-day Redetermination TOPIC PURPOSE CONTACT SIGNED

Wireless Nurse Calling System Technical Document

State of Florida Department of Children and Families

PAPER FOR NHS LUTON COMMUNITY SERVICES BOARD MEETING HELD ON 21 ST APRIL 2010

BBSRC, EPSRC and MRC CASE PhD Studentships A Summary

Licensed School Nurse (LSN) Ohio Revised Code defines the RN scope of practice that is regulated by the Ohio Board of Nursing.

Example Generic Work Schedule 1 (General Practice ST3)

STUDY: OUTPATIENT SURGERY MAGAZINE AGAIN RANKED BEST AMONG SURGERY FACILITY MANAGERS

2018 CMS Web Interface

Vantel Pearls International, Inc. 46 Eastman Street, South Easton, MA Tel Compensation Plan.

Financial Support. Terms and Conditions and Guide for Further Education Students at Brooksby Melton College 2017/18

1. CIMA S SEEDCORN RESEARCH APPLICATION PROCESS: FEASIBILITY STUDIES

CANADA-LUXEMBOURG CO-DEVELOPMENT AND CO-PRODUCTION INCENTIVE FOR AUDIOVISUAL PROJECTS GUIDELINES

Community Development Small Grants Fund. Guidelines 2018

1. Quality outcomes grant funding explained:

p so January 16, 2014

COMMUNITY PHARMACY WARFARIN SERVICE Community Pharmacy Anti-coagulation Management (CPAM) Service

Wood Windows and Doors Application

State Operations Manual Appendix P - Survey Protocol for Long Term Care Facilities - Part I

Summer Leisure 2018 Registration March 21, Adelaide Street, South 5 p.m. 7:00 p.m.

JOB DESCRIPTION. (Whilst on duty, the post holder will report to the Shift Manager)

Academic Health Center Mayo Mail Code Delaware Street SE, Minneapolis, MN nexusipe.

Admission Agreement (SMOKE FREE CAMPUSES)

Odessa College Associate Degree Program Admissions Guide

Transcription:

NHS TAYSIDE Special Frmulatin and Unlicensed Prducts in Primary Care A Guide fr Pharmacists Wrking Within NHS Tayside Guideline Manager Diane Rbertsn, Principal Pharmacist, Cmmunity Pharmacy Develpment Cnsultatin Grup See Page 8 Apprved by Directr f Pharmacy, Frances Rney Guideline Established Octber 2013 Guideline Review Perid/Expiry Octber 2015 Last Updated December 2013 UNCONTROLLED WHEN PRINTED Identifier: NHST/Guid/Specials_001.2-1 -

This cntrlled dcument shall nt be cpied in part r whle withut the express permissin f the authr r the authr s representative. Special Frmulatin and Unlicensed Prducts In Primary Care - A Guide Fr Pharmacists Wrking Within NHS Tayside Cntents Page N 1. Intrductin 3 2. Guidance And Further Reading 3 3. Definitin Of A Special 4 4. Prescribed Specials The Prescriber s Respnsibilities 4 5. Prescribed Specials The Pharmacist s Respnsibilities 5 6. Prcess Fr Checking, Authrising And Ordering A Special Fr A 5 Prescriptin 7. Prduct Specificatin 7 8. Pre-Authrisatin Of Specified Prducts 7 9. Prducts Initiated In Hspital 7 10. Payment Or Reimbursement By Practitiner Services Divisin 7 (PSD) 11. Summary 8 12. Cnsultatin Grup 9 Appendix 1: Cntact Infrmatin 10 Appendix 2: Algrithm Of Supply Prcess Fr A Special 11 Appendix 3: Request Frm Fr Authrisatin T Order A Special 12 Acknwledgment This dcument was based n an riginal dcument cmmissined by the Scttish CAPO Grup in Octber 1997. It was updated by Dn Page, Technical Services Pharmacist, Infrmatin and Statistics Divisin and issued by the Assciatin f Scttish Trust Chief Pharmacists and was been adapted t meet NHS Grampian needs. NHS Tayside has further adapted the dcument t meet NHS Tayside requirements. Identifier: NHST/Guid/Specials_001.2-2 -

Special Frmulatin And Unlicensed Prducts In Primary Care - A Guide Fr Pharmacists Wrking Within NHS Tayside 1. Intrductin This guidance cvers the rdering and supply f special frmulatins and unlicensed prducts (Specials) in Primary Care within NHS Tayside. It is recgnised that it is smetimes necessary that specials are prescribed in Primary Care but the patient, prescriber and supplying pharmacist shuld all be aware when a special is being used and the implicatins f that. This guidance aims t: Supprt the new Part 7S and Part 7U f the Scttish Drug Tariff. Supprt lcal implementatin f Medicines and Healthcare prducts Regulatry Authrity (MHRA), Ryal Pharmaceutical Sciety (RPS) and General Medical Cuncil (GMC) advice. Ensure that unlicensed, expensive specials are nt prescribed when apprpriate licensed r mre cst effective alternatives are available. Remind pharmacists and prescribers f their respnsibilities and liabilities with regard t the supply f specials. Outline the crrect prcess t ensure pharmacists/prescribers: fulfil their legal and prfessinal respnsibilities. knw under what circumstances authrisatin is a requirement fr a special. knw hw t btain authrisatin fr a special. knw hw t ensure full remuneratin fr the specials they supply. 2. Guidance And Further Reading Further guidance n specials can be fund at: SHOW at: http://www.sehd.sct.nhs.uk/pca/pca2013(p)04.pdf MHRA at: http://www.mhra.gv.uk/hwweregulate/medicines/desmyprductneedalicence/me dicinesthatdntneedalicence/index.htm. Ryal Pharmaceutical Sciety at: http://www.rpharms.cm/pharmacy-practice-resurce/specials.asp General Medical Cuncil at: http://www.gmc-uk.rg/static/dcuments/cntent/prescribing_guidance_(2013).pdf Identifier: NHST/Guid/Specials_001.2-3 -

NELM at: QA294Therapeutic ptins fr patients unable t take slid dsage frms - http://www.nelm.nhs.uk/en/nelm-area/evidence/medicines-q--a/therapeuticptins-fr-patients-unable-t-take-slid-ral-dsage-frms/ Ryal Cllege f Paediatrics and Child Health at: The use f unlicensed medicines r licensed medicines fr unlicensed applicatins in paediatric practice - http://www.rcpch.ac.uk/system/files/prtected/page/rcpch%20revised%20stateme nt%20n%20unlicensed%20medicines%20octber%202010%20final.pdf 3. Definitin Of A Special The term special can be applied t any Medicinal Prduct, as defined by the Medicines Act 1968, that des nt hld a full Marketing Authrisatin (MA) r Prduct Licence (PL) r Eurpean Medicines Evaluatin Authrity Licence (EMEA). Fr the purpses f this guideline, the prducts may include: Nn-standard and therefre unlicensed strengths f existing licensed medicines. Nn-standard presentatins f existing active ingredients. Nn Eurpean Medicines Evaluatin Agency (EMEA) apprved imprted prducts (nt therwise available in the United Kingdm). Other prducts nt therwise cmmercially available. Please nte that the MHRA guidance n specials des nt apply t a prduct made up directly by the pharmacist, n the direct rder f a dctr r a dentist, fr a specific patient, if the prescriptin frm is within the building where the cmpunding is ccurring (i.e. extempraneus dispensing f a prescriptin by the pharmacist in their pharmacy). 4. Prescribed Specials The Prescriber s Respnsibilities A prduct hlding a Marketing Authrisatin (MA) will d s fllwing evaluatin by the MHRA r EMEA f all data regarding the prduct frm Indicatins and Dses thrugh t the surce f raw materials, precise methd and lcatin f manufacture and Quality Checks prvided thrugh the whle manufacturing prcess. The MA Hlder is bliged t ensure that full Prduct Infrmatin is supplied t bth the prescriber and dispenser f the prduct. The marketing Authrisatin cnfers liability upn the Hlder fr the prduct in use when the terms f the license are cmplied with. This means that in the extremely rare event f misadventure where the cause can be slely attributed t the prduct, and it can be prved that the prduct was prescribed and used in accrdance with the terms f the Marketing Authrisatin the Hlder is liable fr any claim that may be entertained. Fr an unlicensed prduct, n such liability exists. The prescriber bears clinical respnsibility fr prescribing the prduct. The prescriber shuld fully understand that prescribers f unlicensed medicines, r medicines prescribed ut with their marketing authrisatin (ff-label), have a persnal liability fr their prescriptin that cannt be transferred t the manufacturer r imprter f the medicine. (The prescriber shuld ask themselves whether an Identifier: NHST/Guid/Specials_001.2-4 -

acceptable licensed prduct might be suitable instead.) 5. Prescribed Specials Pharmacist s Respnsibilities The pharmacist directly supplying a special bears shared clinical respnsibility with the prescriber as t the suitability and safety f the prduct fr use by the individual patient. The pharmacist is als cnsidered the prducer f the prduct (under the Medicines Act) and bears direct respnsibility fr the frmulatin, quality, presentatin and labelling f the prduct and that it meets dispensing standards. It shuld be nted that a specials manufacturer license is specific t bth the premises and the prduct. Sme manufacturers may make prducts that are nt cvered by their license and it is up t the pharmacist rdering the prduct t ensure that the item rdered is cvered by the specials license. Supply f a special shuld nt be entered int withut due cnsideratin f the needs f the patient and suitability f the special and must nly be cnsidered if there is n suitable licensed prduct available. When presented with a prescriptin fr a special r unlicensed prduct fr a patient, the pharmacist as purchaser f the item has clear prfessinal duties t discuss the apprpriateness f the medicatin with the prescriber in terms f: availability f any licensed prduct that is therapeutically equivalent. Infrming/reminding the prescriber f their respnsibilities in prescribing a special including: that they (the prescriber) will bear clinical respnsibility fr prescribing an unlicensed prduct. that full prescribing infrmatin abut the prduct is nt always available. the cst invlved in btaining the prduct. the timescale fr btaining the prduct. The pharmacist must infrm/remind the patient that the prduct being dispensed is an unlicensed r special prduct and the implicatins f this, e.g. unlicensed, time delay etc. 6. Prcess Fr Checking, Authrising And Ordering A Special Fr A Prescriptin When a prescriptin fr a special is received in the pharmacy the fllwing steps and checks shuld be undertaken in every case. (1) Check if the patient has had the item dispensed befre. (2) Check if the special is clinically suitable fr the patient. (3) Check the BNF t see if a licensed alternative is available either in a different frm r as an alternative prprietary prduct in the same class. (4) Check if any licensed prducts culd be used in an unlicensed way, e.g. tablets crushed r dispersed, r capsules pened. Is using a prduct in this way biequivalent t the riginal? The UKMI dcument Therapeutic ptins fr patients unable t take slid ral dsage frms may be a useful Identifier: NHST/Guid/Specials_001.2-5 -

reference: http://www.nelm.nhs.uk/en/original-search/?query=therapeutic+ptins+fr+patients+unable. (5) Determine the specific frmulatin that is required fr the special. (6) Determine if the prduct can be extempraneusly prepared. (7) Use the frmulatin and additinal infrmatin n packaging, labelling, strage, and expiry t frm a specificatin fr the prduct. (8) Where the prduct is nt exempt frm authrisatin as detailed in para 11 belw the pharmacist shuld request csting infrmatin frm at least tw specials cmpanies r whlesalers based n this specificatin (including pstage and packing, delivery r handling charges). Nte: At this pint it may als be useful t check with these suppliers if alternative frms r strengths f the preparatin requested are available mre readily (e.g. a higher strength liquid which wuld enable the prescribed dse t be easily given via an ral syringe). Als check the mst cst effective quantity t purchase, e.g. 100 tablets may cst less than the 56 required. (9) Cntact the prescriber t prvide infrmatin n alternative prducts, csts, time scales and t discuss the prduct ptins fr the patient (strength, frmulatin, frm, presentatin). (10) Agree the mst apprpriate ptin fr the patient. (11) If the prescriber cnfirms that the special is the mst apprpriate prduct fr the patient then NHS Tayside authrisatin must be btained prir t rdering the special unless the prduct: is listed in Part 7S r Part 7U f the Drug Tariff. can be prepared extempraneusly in the pharmacy is available frm Tayside Pharmaceuticals r Glasgw Western Infirmary Pharmaceutical Prductin Unit. is a repeat prescriptin fr a specific patient and prduct where an authrisatin number has previusly been granted fr either 6 r 12 mnths, prvided the cst has nt increased since the last dispensing and the authrisatin is still valid. (12) NHS Tayside authrisatin can be requested fllwing e-mail submissin f the fully cmpleted Request Frm fr Authrisatin t Order Specials. Requests must be emailed t pharmacyspecials.tayside@nhs.net. (13) A 6 r 12 mnth authrisatin may in sme cases be granted fr individual patients n a lng term unlicensed medicine. If this is required this shuld be specified n the individual request. This is at the discretin f the authrising fficer. (14) An authrisatin cde will be e-mailed back t the senders e-mail address r failing that, further investigatin r alternative supply arrangements suggested. (15) An email reply will be sent within 24 hurs Mnday t Friday. If an email reply has nt been received with 24 hurs r the request is urgent the pharmacist shuld call 01382 596992. (16) When authrisatin is given, pharmacists will be prvided with an authrisatin cde, which they shuld then add int the bx prvided in their cpy f the request frm if the frm has nt been sent back with this incrprated. (17) Order the prduct frm the agreed surce. (18) When rdering a special, the pharmacist must als btain a Certificate f Analysis (COA) r Certificate f Cnfrmity (COC) frm the supplier. Identifier: NHST/Guid/Specials_001.2-6 -

(19) Each mnth the pharmacist will submit t Diane Rbertsn, (Cmmunity Pharmacy Develpment, Pharmacy Department, East Day Hme, Kings Crss Hspital, Clepingtn Rad, Dundee DD3 8EA), a cpy f all COA/ COCs fr specials received in that mnth, each apprpriately endrsed (see PCA(P)(20013)4 pint 6 and Appendix 1 (cntact infrmatin)). (20) Apprpriate recrds f the supply must be kept fr 5 years. (21) Fr queries regarding specials (nt authrisatin) pharmacists shuld either email as per the authrisatin email address (if nt urgent) r call 01382 596992 and ask t speak t Diane Rbertsn, David Gill r David Culsn with a specials query. A flw chart Algrithm f Supply Prcess fr a Special f the steps required in rder t make a supply is available in Appendix 3. 7. Prduct Specificatin It is the respnsibility f the pharmacist supplying a special t understand and define the specificatin and frmulatin f the prduct that they require frm the specials manufacturer. As part f this, it is necessary fr the pharmacist t fully understand the intended use f the medicine. The specificatin will include infrmatin n frmula, labelling and the strage requirements f the prduct and any ther apprpriate details, e.g. any patient infrmatin. 8. Pre-Authrisatin Of Specified Prducts NHS Tayside has pre-authrised all specials prducts available and surced frm either Tayside Pharmaceuticals r Glasgw Western General Pharmaceutical Prductin Unit i.e. n request fr authrisatin frm is required. 9. Prducts Initiated In Hspital If a patient has been discharged frm hspital n a special, the hspital pharmacist can be cntacted fr advice and the Ninewells Area Pharmacy Office fr the specificatin and frmulatin that was used and the surce f supply. Where difficulty f supply is an issue, the hspital cncerned may be willing t supply the prduct r prvide a suitable frmula fr extempraneus preparatin in the pharmacy. This wuld be at the discretin f the hspital pharmacy, and wuld take accunt f clinical respnsibility fr the patient, where this has been retained by the hspital specialist. Where the prduct is supplied in this way, the pharmacy will be inviced by the hspital fr the prduct, and this invice can be sent with the prescriptin (suitably endrsed) when it is submitted fr payment t PSD. 10. Payment Or Reimbursement By Practitiner Services Divisin (PSD) Infrmatin n payment fr specials is given in the Scttish Drug Tariff, Part 7S at: http://www.isdsctland.rg/health-tpics/prescribing-and-medicines/scttish-drug- Tariff/Dcs/SDT_Part7S_Preface.pdf. Part 7U at: http://www.isdsctland.rg/health-tpics/prescribing-and-medicines/scttish-drug- Tariff/Drugs-and-Preparatins-with-Tariff-Prices.asp Identifier: NHST/Guid/Specials_001.2-7 -

Full instructins fr required paperwrk and endrsements fr specials prescriptins are available in PCA(P)(2013)4 n the Scttish Health n the Web (SHOW) website http://www.sehd.sct.nhs.uk/pca/pca2013(p)04.pdf and in the Scttish Drug Tariff. In line with MHRA Guidance, prescriptins fr special frmulatins that are deemed t be pharmaceutically equivalent t an existing licensed prduct wuld nt be paid at invice price unless it is prved that the licensed versins were genuinely unavailable r unsuitable fr the patient. PSD maintains a list f prducts that are frmally unbtainable, and this may be checked by cntacting ne f the pricing ffices r checking the Scttish Drug Tariff. Pharmacists are reminded that under the RPS guidance they have an bligatin t seek best value fr the NHS. It is expected that in discharging their bligatin pharmacies will btain qutatins fr a particular prduct frm different suppliers prir t requesting authrisatin t rder a special. 11. Summary There are ccasins when after discussin with the prescriber, the patient s needs dictate that there is n ther chice than t supply a special prduct. This NHS Tayside dcument describes the acceptable prcesses fr btaining a special which will guarantee full reimbursement f the cst f that special. Where pharmacies are surcing prducts frm ther suppliers, pharmacies require authrisatin frm NHS Tayside prir t rdering. Failure t fllw the prcesses in this guidance, and in particular failure t apply fr authrisatin where needed, will result in pharmacies nt being fully reimbursed fr the specials medicines they have supplied. The fllwing directins apply: The Scttish Drug Tariff cntains a list f specials that attract a set reimbursement payment and which may be rdered withut prir authrisatin (Part 7S and Part 7U) Extempraneus preparatin, within the pharmacy, shuld be cnsidered. Where either Tayside Pharmaceuticals r Glasgw Western Infirmary prductin units are used t btain specials, these specials may be rdered withut prir authrisatin. Authrisatin fr Specials must be btained prir t rdering except where the prducts are in Part 7S r Part 7U f the Drug tariff, r prepared extempraneusly, r available frm Tayside Pharmaceuticals r Glasgw Western Infirmary Pharmaceutical Prductin Unit. Authrisatin must be requested by submitting the request frm (Appendix 3) t pharmacyspecials.tayside@nhs.net. Pharmacy cntractrs must nt prceed with rdering r supply f the item unless authrisatin has been granted. Where authrisatin is nt granted further directin will be given. Pharmacy cntractrs must keep full recrds f prcurement and supply f specials. There is a further requirement t submit infrmatin n specials Identifier: NHST/Guid/Specials_001.2-8 -

prducts supplied t NHS Tayside each mnth, in accrdance with PCA(P)(2013)4 item 6. The prescriptin shuld be endrsed as previusly with the additin f the authrisatin cde. 12. Cnsultatin Grup Frances Rney David Culsn David Gill Diane Rbertsn Directr f Pharmacy Acting Head f Medicines Gvernance Head f Pharmacy Angus CHP Cmmunity Pharmacy Develpment Area Pharmaceutical Cmmittee Chair and Vice Chair Area Pharmacy Cntractrs Cmmittee Identifier: NHST/Guid/Specials_001.2-9 -

Appendix 1 Cntact Infrmatin Practitiner Services Divisin (Ask fr a Grup Leader) Aberdeen Tel 01224 358300 Edinburgh Tel 0131 557 3733 Glasgw Tel 0141 332 0787 SPGC Tel 0131 467 7766 ISD Custmer Services Desk Tel 0131 551 8899 Scttish Drug Tariff web link MRHA Website ISD http://www.isdsctland.rg/health- Tpics/Prescribing-and-Medicines/Scttish-Drug- Tariff www.mhra.gv.uk http://www.isdsctland.rg/index.asp Tayside Pharmaceuticals Tel 01382 632 052 Fax 01382 632060 Ninewells Area Pharmacy Tel 01382 632036 Fax 01382 632822 Office pharmacyffice.tayside@nhs.net Glasgw Western General Tel 0141 211 2754 Fax 0141 2111967 Pharmaceutical Prductin Unit Medicines Infrmatin Department, Ninewells Pharmacy Medicines Gvernance Fr enquiries regarding specials Tel 01382 632351 Email Tay-UHB.medinf@nhs.net Tel 01382 596992 Fr authrisatin f specials requests All requests shuld be emailed pharmacyspecials.tayside@nhs.net Authrisatin Officers Lead Officer Diane Rbertsn 01382 596992 dianerbertsn3@nhs.net David Gill 01382 596992 david.gill@nhs.net 01382 596992 David Culsn david.culsn@nhs.net Identifier: NHST/Guid/Specials_001.2-10 -

Algrithm Of Supply Prcess Fr A Special Appendix 2 The pharmacist shuld cntact the prescriber t discuss the need fr special and t cnsider if: a special is necessary a licensed prduct f a different strength r frm is available as an acceptable alternative tablet frmulatin can be crushed and disslved r dispersed r capsules pened the cst is acceptable. Fllwing this discussin, des the prescriber still wish t prescribe the special? N Yes Identify prduct specificatin Agree alternative arrangements as required Is the prduct listed in Part 7S r 7U f the Drug Tariff? Can yu apprpriately prepare the prduct extempraneusly? Is the prduct available frm Tayside Pharmaceuticals r Glasgw Western Infirmary? N Cmplete and submit email authrisatin request t pharmacyspecials.tayside@nhs.net including apprpriate qute If the answer t all f these is N If the answer t any ne f these is Yes Has request been authrised? Yes Make a supply Make the apprpriate endrsements and submissins and keep secure recrds as required UNCONTROLLED WHEN PRINTED Review Date: September 2015 Special Frmulatin and Unlicensed Prducts in Primary care: A Guide fr Pharmacists Versin 1.1 Identifier: NHST/Guid/Specials_001.1-11 -

Versin 1.1 Octber 2013 Appendix 3 NHS Tayside Request Frm fr Authrisatin t Order Specials This frm must be cmpleted if the prduct requested des nt fall int ne f the fllwing categries: Is listed in part 7S r part 7U f the Drug Tariff Can be prepared extempraneusly in the pharmacy Is available frm Tayside Pharmaceuticals r Glasgw Western Infirmary Pharmacy Prductin Unit pre-authrised. Is a repeat prescriptin fr a specific patient and prduct where an authrisatin number has previusly been granted fr either 6 r 12 mnths, prvided the cst has nt increased since the last dispensing and the authrisatin is valid. Patient must be reviewed each time as per plicy t ensure apprpriate. Please remember t lk at ther ptins and reasns fr prescribing befre autmatically prceeding t rder as a special in all cases. T be emailed t pharmacyspecials.tayside@nhs.net Cntact Number fr enquiries 01382 596992 Pharmacy Cntractr Cde Name and address f Cmmunity Pharmacy Telephne Number Cmmunity Pharmacists Name Prescribers Name and General Practice (r ther surce) Practice Cde CHI Prduct Details (Name, Frm, Strength, Dse, Quantity) Quted Cst (Excluding VAT) fr FULL quantity Cheapest f at least 2 qutes Additinal Csts (Pstage/Carriage) Supplier Details Cmments r Exceptinal Circumstances Please specify r request is fr this script nly r if it is a lng term patient request fr 6 mnths r 12 mnths. Authrisatin is fr this prescriptin nly 6 mnths (until) / / (insert date) 12 mnths (until) / / (insert date) Authrisatin Number Authrising Officer Date This prduct has nt been authrised (give alternate instructins) Recrds f all special prducts must be kept as detailed in part 6 f the circular (http://www.sehd.sct.nhs.uk/pca/pca2013(p)04.pdf) A cpy f the endrsed COA/COC (r invice) as per pint 6 f the circular must be sent t the Pharmacy Department, East Day Hme at the end f each mnth. Please remember t endrse the authrisatin cde n prescriptin and paperwrk A cpy f the invice fr the prduct shuld be submitted with the prescriptin when it is sent fr pricing. UNCONTROLLED WHEN PRINTED Review Date: September 2015 Special Frmulatin and Unlicensed Prducts in Primary care: A Guide fr Pharmacists Versin 1.1 Identifier: NHSG/Guid/Specials_001.1-12-